title: Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease.
authors.affiliation: Gastro-Immuno Research Laboratory, Department of Medicine V, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. chrishva@rm.dk
authors.forename: Christian Lodberg
authors.initials: CL
authors.lastname: Hvas
authors.forename: Jens
authors.initials: J
authors.lastname: Kelsen
authors.forename: Jørgen
authors.initials: J
authors.lastname: Agnholt
authors.forename: Anders
authors.initials: A
authors.lastname: Dige
authors.forename: Lisbet Ambrosius
authors.initials: LA
authors.lastname: Christensen
authors.forename: Jens Frederik
authors.initials: JF
authors.lastname: Dahlerup
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D000069285:Infliximab; D016023:Integrins / Q000378:metabolism; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D050378:T-Lymphocytes, Regulatory / Q000166:cytology / Q000276:immunology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D016023:Integrins; C071777:integrin alpha4beta7; D000069285:Infliximab